Treatment of Experimental Subcutaneous Human Melanoma with a Replication-Restricted Herpes Simplex Virus Mutant
Open Access
- 1 June 1997
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 108 (6) , 933-937
- https://doi.org/10.1111/1523-1747.ep12295238
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Current therapy for cutaneous melanomaJournal of the American Academy of Dermatology, 1995
- Inhibition of Melanoma Growth by Adenoviral-Mediated HSV Thymidine Kinase Gene Transfer In VivoJournal of Investigative Dermatology, 1995
- Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus VectorsHuman Gene Therapy, 1994
- An experimental model of retrovirus gene therapy for malignant brain tumorsJournal of Neurosurgery, 1993
- Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.Journal of Clinical Investigation, 1993
- Reduction and Elimination of Encephalitis in an Experimental Glioma Therapy Model with Attenuated Herpes Simplex Mutants that Retain Susceptibility to AcyclovirNeurosurgery, 1993
- Herpes Simplex-1 Virus Thymidine Kinase Gene Is Unable to Completely Eliminate Live, Nonimmunogenic Tumor Cell VaccinesJournal of Immunotherapy, 1992
- Expanded spectrum of viral therapy in the treatment of nervous system tumorsJournal of Neurosurgery, 1992
- Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716Journal of General Virology, 1992
- The JH2604 deletion variant of herpes simplex virus type 2 (HG52) fails to produce necrotizing encephalitis following intracranial inoculation of miceJournal of General Virology, 1990